Back to Search
MARLA POLLACK, PH.D.
PH.D.
Clinical Psychologist
NPI: 1992784508Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
PSY10789(CA)
Clinical Trials (7)
7
Linked Trials
0
Recruiting
5
With Results
Eszopiclone for the Treatment of Posttraumatic Stress Disorder
NCT01605253COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder
NCT00438971COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder
NCT00120250COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
D-Cycloserine Enhancement of Exposure in Social Phobia
NCT00633984COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder
NCT00282828COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Uncomplicated Nausea and Vomiting in the Emergency Department
NCT00778011COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Aripiprazole for the Treatment of Refractory Anxiety
NCT00438386COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
PMID 24399428·Am J Psychiatry·2014
2-rct
D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
PMID 23870811·J Psychiatr Res·2013
2-rct
D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
PMID 23599046·Am J Psychiatry·2013
4-observational
Sleep quality predicts treatment outcome in CBT for social anxiety disorder.
PMID 24038728·Depress Anxiety·2013
4-observational
Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
PMID 21367352·J Clin Psychiatry·2011
2-rct
Open-label support for duloxetine for the treatment of panic disorder.
PMID 19228176·CNS Neurosci Ther·2009
8-other
Quality of life and anxiety disorders: a population study.
PMID 15729110·J Nerv Ment Dis·2005
4-observational
Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.
PMID 15232330·J Clin Psychopharmacol·2004
3-trial
Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.
PMID 12826987·J Clin Psychopharmacol·2003
8-other
Insomnia-related comorbidities and economic costs among a commercially insured population in the United States.
PMID 19530979·Curr Med Res Opin·2009
4-observational
Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
PMID 18480688·J Clin Psychopharmacol·2008
8-other
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
PMID 18458207·Arch Gen Psychiatry·2008
2-rct
The approach to patients with acute GI hemorrhage who cannot receive a blood transfusion.
PMID 18440384·Gastrointest Endosc·2008
6-review
Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint.
PMID 18348888·J Psychiatr Res·2008
4-observational
Novel treatment approaches for refractory anxiety disorders.
PMID 17437259·Depress Anxiety·2008
8-other
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
PMID 18221755·J Psychiatr Res·2008
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 745 S MARENGO AVE, STE 301
PASADENA, CA 91106 - Phone
- (626) 304-0822
Quick Facts
- NPI
- 1992784508
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile